Strategic Projects
- Several US and Germany headquartered, major multinational pharmaceutical companies:
- Global projects to re-engineer and harmonise the global pharmaceutical development and IMP supply chain process
- Introduction of performance measurement by defining and implementing appropriate KPIs according to the balanced scorecard approach
- Optimisation of the IMP process (Quality, Time and Cost), incl. an integrated QA system to support and improve the clinical supply process
- Evaluation, selection and pilot facilitation of a Manufacturing Execution System (MES) to support the global IMP supply chain
- Long-term strategic analysis of manufacturing and sourcing activities to support clinical operations at their three global sites
- Several US headquartered, globally active IMP contract packagers:
- Identification, selection and planning of a completely new facility within EU
- Acquisition Strategies for EU customers
- Evaluation of business options for a European subsidiary and support in its later disposition
- Market surveys on the future outsourcing practices of major pharmaceutical companies